Samuel So

Publications

• Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma. Bu L, Xie J, Chen K, Huang J, Aguilar ZP, Wang A, Sun KW, Chua MS, So S, Cheng Z, Eden HS, Shen B, Chen X. Contrast Media Mol Imaging. 2012 Jul-Aug; 7 (4): 363-72
• Low levels of knowledge and preventive practices regarding vertical hepatitis B transmission among perinatal nurses. Chao SD, Cheung CM, Yang EJ, So SK, Chang ET. J Obstet Gynecol Neonatal Nurs. 2012 Jul-Aug; 41 (4): 494-505
• A model program for hepatitis B vaccination and education of schoolchildren in rural China. Chen JJ, Chang ET, Chen YR, Bailey MB, So SK. Int J Public Health. 2012; 57 (3): 581-8
• The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Willingham SB, Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, Mitra SS, Wang J, Contreras-Trujillo H, Martin R, Cohen JD, Lovelace P, Scheeren FA, Chao MP, Weiskopf K, Tang C, Volkmer AK, Naik TJ, Storm TA, Mosley AR, Edris B, Schmid SM, Sun CK, Chua MS, Murillo O, Rajendran P, Cha AC, Chin RK, Kim D, Adorno M, Raveh T, Tseng D, Jaiswal S, Enger PØ, Steinberg GK, Li G, So SK, Majeti R, Harsh GR, van de Rijn M, Teng NN, Sunwoo JB, Alizadeh AA, Clarke MF, Weissman IL. Proc Natl Acad Sci U S A. 2012; 109 (17): 6662-7
• Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker. Lin AY, Chua MS, Choi YL, Yeh W, Kim YH, Azzi R, Adams GA, Sainani K, van de Rijn M, So SK, Pollack JR. PLoS One. 2011; 6 (2): e16636
• Doing Good with Good OR: Supporting Cost-effective Hepatitis B Interventions. Hutton DW, Brandeau ML, So SK. Interfaces (Providence). 2011; 41 (3): 289-300
• In vivo MRSI of hyperpolarized [1-(13)C]pyruvate metabolism in rat hepatocellular carcinoma. Darpolor MM, Yen YF, Chua MS, Xing L, Clarke-Katzenberg RH, Shi W, Mayer D, Josan S, Hurd RE, Pfefferbaum A, Senadheera L, So S, Hofmann LV, Glazer GM, Spielman DM. NMR Biomed. 2011; 24 (5): 506-13
• San Francisco hep B free: a grassroots community coalition to prevent hepatitis B and liver cancer. Bailey MB, Shiau R, Zola J, Fernyak SE, Fang T, So SK, Chang ET. J Community Health. 2011; 36 (4): 538-51
• Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin. Wei W, Chua MS, Grepper S, So SK. Mol Cancer. 2011: 10 16
• Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-β2. Sun CK, Chua MS, He J, So SK. Neoplasia. 2011; 13 (8): 735-47
• Achieving health equity to eliminate racial, ethnic, and socioeconomic disparities in HBV- and HCV-associated liver disease. El-Serag H, McGlynn KA, Graham GN, So S, Howell CD, Fang T, Anderson JT, Thiel TK. J Fam Pract. 2010; 59 (4 Suppl): S37-42
• Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China. Hutton DW, So SK, Brandeau ML. Hepatology. 2010; 51 (2): 405-14
• Disparities in liver cancer incidence by nativity, acculturation, and socioeconomic status in California Hispanics and Asians. Chang ET, Yang J, Alfaro-Velcamp T, So SK, Glaser SL, Gomez SL. Cancer Epidemiol Biomarkers Prev. 2010; 19 (12): 3106-18
• Hepatitis B and liver cancer knowledge and practices among healthcare and public health professionals in China: a cross-sectional study. Chao J, Chang ET, So SK. BMC Public Health. 2010: 10 98
• Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo. Wei W, Chua MS, Grepper S, So S. Int J Cancer. 2010; 126 (10): 2426-36
• Eliminating the threat of chronic hepatitis B in the Asian and Pacific Islander community: a call to action. Chao SD, Chang ET, So SK. Asian Pac J Cancer Prev. 2009 Jul-Sep; 10 (3): 507-12
• Stopping a silent killer in the underserved asian and pacific islander community: a chronic hepatitis B and liver cancer prevention clinic by medical students. Lin SY, Chang ET, So SK. Asian Pac J Cancer Prev. 2009 Jul-Sep; 10 (3): 383-6
• 3 For Life: a model pilot program to prevent hepatitis B virus infection and liver cancer in Asian and Pacific Islander Americans. Chang ET, Sue E, Zola J, So SK. Am J Health Promot. 2009 Jan-Feb; 23 (3): 176-81
• Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells. Wei W, Chua MS, Grepper S, So SK. Mol Cancer. 2009: 8 76
• Frequent inactivation of axon guidance molecule RGMA in human colon cancer through genetic and epigenetic mechanisms. Li VS, Yuen ST, Chan TL, Yan HH, Law WL, Yeung BH, Chan AS, Tsui WY, So S, Chen X, Leung SY. Gastroenterology. 2009; 137 (1): 176-87
• Phase I/II study of PHY906/capecitabine in advanced hepatocellular carcinoma. Yen Y, So S, Rose M, Saif MW, Chu E, Liu SH, Foo A, Jiang Z, Su T, Cheng YC. Anticancer Res. 2009; 29 (10): 4083-92
• The Jade Ribbon Campaign: a model program for community outreach and education to prevent liver cancer in Asian Americans. Chao SD, Chang ET, Le PV, Prapong W, Kiernan M, So SK. J Immigr Minor Health. 2009; 11 (4): 281-90
• Attitudes toward hepatitis B and liver cancer prevention among Chinese Americans in the San Francisco Bay Area, California. Chang ET, Nguyen BH, So SK. Asian Pac J Cancer Prev. 2008 Oct-Dec; 9 (4): 605-13
• Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma. Sun H, Chua MS, Yang D, Tsalenko A, Peter BJ, So S. Biomark Insights. 2008: 3 1-18
• N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. Yan X, Chua MS, Sun H, So S. Cancer Lett. 2008; 262 (1): 133-42
• Phase II study of imatinib in unresectable hepatocellular carcinoma. Lin AY, Fisher GA, So S, Tang C, Levitt L. Am J Clin Oncol. 2008; 31 (1): 84-8
• Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo. Yan X, Chua MS, He J, So SK. Mol Cancer. 2008: 7 19
• Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California. Wu CA, Lin SY, So SK, Chang ET. Asian Pac J Cancer Prev. 2007 Jan-Mar; 8 (1): 127-34
• Building partnerships with traditional chinese medicine practitioners to increase hepatitis B awareness and prevention. Chang ET, Lin SY, Sue E, Bergin M, Su J, So SK. J Altern Complement Med. 2007; 13 (10): 1125-7
• Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B. Hutton DW, Tan D, So SK, Brandeau ML. Ann Intern Med. 2007; 147 (7): 460-9
• Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Chua MS, Sun H, Cheung ST, Mason V, Higgins J, Ross DT, Fan ST, So S. Mod Pathol. 2007; 20 (1): 76-83
• Re: "Ten largest racial and ethnic health disparities in the United States based on Healthy People 2010 objectives". Chang ET, So SK. Am J Epidemiol. 2007; 166 (9): 1105-6; author reply 1106-7
• The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004. Chang ET, Keegan TH, Gomez SL, Le GM, Clarke CA, So SK, Glaser SL. Cancer. 2007; 109 (10): 2100-8
• Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California. Lin SY, Chang ET, So SK. Hepatology. 2007; 46 (4): 1034-40
• Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma. Chua MS, Bernstein LR, Li R, So SK. Anticancer Res. 2006 May-Jun; 26 (3A): 1739-43
• Comprehensive analysis of 19q12 amplicon in human gastric cancers. Leung SY, Ho C, Tu IP, Li R, So S, Chu KM, Yuen ST, Chen X. Mod Pathol. 2006; 19 (6): 854-63
• Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma. Fong CW, Chua MS, McKie AB, Ling SH, Mason V, Li R, Yusoff P, Lo TL, Leung HY, So SK, Guy GR. Cancer Res. 2006; 66 (4): 2048-58
• Topological and functional discovery in a gene coexpression meta-network of gastric cancer. Aggarwal A, Guo DL, Hoshida Y, Yuen ST, Chu KM, So S, Boussioutas A, Chen X, Bowtell D, Aburatani H, Leung SY, Tan P. Cancer Res. 2006; 66 (1): 232-41
• An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma. Patil MA, Chua MS, Pan KH, Lin R, Lih CJ, Cheung ST, Ho C, Li R, Fan ST, Cohen SN, Chen X, So S. Oncogene. 2005; 24 (23): 3737-47
• Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. Patil MA, Gütgemann I, Zhang J, Ho C, Cheung ST, Ginzinger D, Li R, Dykema KJ, So S, Fan ST, Kakar S, Furge KA, Büttner R, Chen X. Carcinogenesis. 2005; 26 (12): 2050-7
• Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. Cheung ST, Leung KL, Ip YC, Chen X, Fong DY, Ng IO, Fan ST, So S. Clin Cancer Res. 2005; 11 (2 Pt 1): 551-6
• Liver tumor gross margin identification and ablation monitoring during liver radiofrequency treatment. Hsu CP, Razavi MK, So SK, Parachikov IH, Benaron DA. J Vasc Interv Radiol. 2005; 16 (11): 1473-8
• Mutations of PIK3CA in gastric adenocarcinoma. Li VS, Wong CW, Chan TL, Chan AS, Zhao W, Chu KM, So S, Chen X, Yuen ST, Leung SY. BMC Cancer. 2005: 5 29
• Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma. Lin AY, Brophy N, Fisher GA, So S, Biggs C, Yock TI, Levitt L. Cancer. 2005; 103 (1): 119-25
• Transcript AA454543 is a novel prognostic marker for hepatocellular carcinoma after curative partial hepatectomy. Cheung ST, Ho JC, Leung KL, Chen X, Fong DY, So S, Fan ST. Neoplasia. 2005; 7 (2): 91-8
• Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer. Leung SY, Yuen ST, Chu KM, Mathy JA, Li R, Chan AS, Law S, Wong J, Chen X, So S. Gastroenterology. 2004; 127 (2): 457-69
• Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma. Cheung ST, Wong SY, Leung KL, Chen X, So S, Ng IO, Fan ST. Clin Cancer Res. 2004; 10 (22): 7629-36
• Novel endothelial cell markers in hepatocellular carcinoma. Chen X, Higgins J, Cheung ST, Li R, Mason V, Montgomery K, Fan ST, van de Rijn M, So S. Mod Pathol. 2004; 17 (10): 1198-210
• Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma. Chan AS, Tsui WY, Chen X, Chu KM, Chan TL, Chan AS, Li R, So S, Yuen ST, Leung SY. Oncogene. 2003; 22 (44): 6946-53
• One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience. Millan MT, Berquist WE, So SK, Sarwal MM, Wayman KI, Cox KL, Filler G, Salvatierra O, Esquivel CO. Transplantation. 2003; 76 (10): 1458-63
• Variation in gene expression patterns in human gastric cancers. Chen X, Leung SY, Yuen ST, Chu KM, Ji J, Li R, Chan AS, Law S, Troyanskaya OG, Wong J, So S, Botstein D, Brown PO. Mol Biol Cell. 2003; 14 (8): 3208-15
• Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines. Ji J, Chen X, Leung SY, Chi JT, Chu KM, Yuen ST, Li R, Chan AS, Li J, Dunphy N, So S. Oncogene. 2002; 21 (42): 6549-56
• Epstein-Barr virus infection is associated with endothelial Bcl-2 expression in transplant liver allografts. Millan MT, Natkunam Y, Clarke-Katzenberg R, Desai D, Prapong W, So SK, Esquivel CO, Sibley R, Ferran C, Martinez OM. Transplantation. 2002; 73 (3): 465-9
• Gene expression patterns in human liver cancers. Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, Lai KM, Ji J, Dudoit S, Ng IO, Van De Rijn M, Botstein D, Brown PO. Mol Biol Cell. 2002; 13 (6): 1929-39
• Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor. Cheung ST, Chen X, Guan XY, Wong SY, Tai LS, Ng IO, So S, Fan ST. Cancer Res. 2002; 62 (16): 4711-21
• Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Leung SY, Chen X, Chu KM, Yuen ST, Mathy J, Ji J, Chan AS, Li R, Law S, Troyanskaya OG, Tu IP, Wong J, So S, Botstein D, Brown PO. Proc Natl Acad Sci U S A. 2002; 99 (25): 16203-8
• Treatment of hepatocellular carcinoma with sub-selective transcatheter arterial oily chemoinfusion. Kim P, Prapong W, Sze DY, So SK, Razavi MK. Tech Vasc Interv Radiol. 2002; 5 (3): 127-31
• CMV and EBV-PTLD after liver transplantation. So S, Transplant Proc. 2001 Feb-Mar; 33 (1-2): 1317-9
• Center experience in liver transplantation for hepatocellular carcinoma associated with cirrhosis. Lai KM, Millan M, Razavi M, Keeffe EB, Prapong W, Fisher GA, Esquivel CO, So SK. Transplant Proc. 2001 Feb-Mar; 33 (1-2): 1490-1
• Impact of multidetector CT hepatic arteriography on the planning of chemoembolization treatment of hepatocellular carcinoma. Sze DY, Razavi MK, So SK, Jeffrey RB. AJR Am J Roentgenol. 2001; 177 (6): 1339-45
• A 100% 2-year graft survival can be attained in high-risk 15-kg or smaller infant recipients of kidney allografts. Millan MT, Sarwal MM, Lemley KV, Yorgin P, Orlandi P, So S, Alexander S, Salvatierra O. Arch Surg. 2000; 135 (9): 1063-8; discussion 1068-9
• Intravenous ribavirin therapy for adenovirus pneumonia. Shetty AK, Gans HA, So S, Millan MT, Arvin AM, Gutierrez KM. Pediatr Pulmonol. 2000; 29 (1): 69-73
• Significance of detecting Epstein-Barr-specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients. Krieger NR, Martinez OM, Krams SM, Cox K, So S, Esquivel CO. Liver Transpl. 2000; 6 (1): 62-6
• Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis? So SK, Esquivel CO, Imperial JC, Garcia G, Monge H, Keeffe EB. J Gastroenterol Hepatol. 1999: 14 Suppl S48-52
• Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. Cacciarelli TV, Keeffe EB, Moore DH, Burns W, Busque S, Concepcion W, So SK, Esquivel CO. Arch Surg. 1999; 134 (1): 25-9
• Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus. Cao S, Cox KL, Berquist W, Hayashi M, Concepcion W, Hammes GB, Ojogho OK, So SK, Frerker M, Castillo RO, Monge H, Esquivel CO. Pediatr Transplant. 1999; 3 (1): 22-6
• Major hepatic resection without blood transfusion: experience with total vascular exclusion. So SK, Monge H, Esquivel CO. J Gastroenterol Hepatol. 1999: 14 Suppl S28-31
• Resection versus transplantation for hepatocellular carcinoma. Esquivel CO, Keeffe EB, Garcia G, Imperial JC, Millan MT, Monge H, So SK. J Gastroenterol Hepatol. 1999: 14 Suppl S37-41
• Allograft rejection after liver transplantation for autoimmune liver diseases. Hayashi M, Keeffe EB, Krams SM, Martinez OM, Ojogho ON, So SK, Garcia G, Imperial JC, Esquivel CO. Liver Transpl Surg. 1998; 4 (3): 208-14
• Current status of living-related liver transplantation. Hayashi M, Cao S, Concepcion W, Monge H, Ojogho O, So S, Esquivel CO. Pediatr Transplant. 1998; 2 (1): 16-25
• Experience with the piggyback technique without caval occlusion in adult orthotopic liver transplantation. Busque S, Esquivel CO, Concepcion W, So SK. Transplantation. 1998; 65 (1): 77-82
• Increased dosage requirement and rejection after Neoral conversion in pediatric liver transplant patients. Cao S, Cox KL, Berquist W, So S, Concepcion W, Monge H, Esquivel CO. Transplant Proc. 1998; 30 (8): 4322-4
• Indications for pediatric liver transplantation. McDiarmid SV, Millis MJ, Olthoff KM, So SK. Pediatr Transplant. 1998; 2 (2): 106-16
• Liver transplantation at Stanford University Medical Center. Millan MT, Keeffe EB, Berquist WE, Castillo RO, Cox KL, Garcia G, Imperial JC, Monge H, So SK, Esquivel CO. Clin Transpl. 1998: 287-96
• Liver transplantation in the first three months of life. Woodle ES, Millis JM, So SK, McDiarmid SV, Busuttil RW, Esquivel CO, Whitington PF, Thistlethwaite JR. Transplantation. 1998; 66 (5): 606-9
• Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keefe EB, Kneteman NM, Lake JR, Martin P, Rakela J, Shiffman ML, So S, Wiesner RH. Transplantation. 1998; 66 (7): 956-62
• Posttransplant lymphoproliferative disorders and gastrointestinal manifestations of Epstein-Barr virus infection in children following liver transplantation. Cao S, Cox K, Esquivel CO, Berquist W, Concepcion W, Ojogho O, Monge H, Krams S, Martinez O, So S. Transplantation. 1998; 66 (7): 851-6
• Orthotopic liver transplantation from non-heart-beating donor rats: effect of flushing with cold/warm UW/SLS preservation solutions. Tojimbara T, Winston WN, So SK, Esquivel CO. Transplant Proc. 1997 Feb-Mar; 29 (1-2): 1371-3
• Emergency transjugular intrahepatic portosystemic shunt (TIPS) in an infant: a case report. Cao S, Monge H, Semba C, Cox KL, Berquist W, Concepcion W, So SK, Esquivel CO. J Pediatr Surg. 1997; 32 (1): 125-7
• Factors affecting survival after orthotopic liver transplantation in infants. Cacciarelli TV, Esquivel CO, Moore DH, Cox KL, Berquist WE, Concepcion W, Hammer GB, So SK. Transplantation. 1997; 64 (2): 242-8
• Liver transplantation in Asian patients with chronic hepatitis B. Ho BM, So SK, Esquivel CO, Keeffe EB. Hepatology. 1997; 25 (1): 223-5
• Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keeffe EB, Kneteman NM, Lake JR, Martin P, McDiarmid SV, Rakela J, Shiffman ML, So SK, Wiesner RH. Liver Transpl Surg. 1997; 3 (6): 628-37
• Potential effect of cyclosporin A in formation of cholesterol gallstones in pediatric liver transplant recipients. Cao S, Cox K, So SS, Berquist W, Lee SP, Haigh WG, Concepcion W, Monge H, Esquivel CO. Dig Dis Sci. 1997; 42 (7): 1409-15
• Superior outcomes in pediatric renal transplantation. Salvatierra O, Alfrey E, Tanney DC, Mak R, Hammer GB, Krane EJ, So SK, Lemley K, Orlandi PD, Conley SB. Arch Surg. 1997; 132 (8): 842-7; discussion 847-9
• Transjugular intrahepatic portosystemic shunt placement in a child complicated by perforated Roux-en-Y portoenterostomy. Wang J, Cox KL, Dake M, Esquivel CO, So SK. J Pediatr Gastroenterol Nutr. 1997; 25 (4): 421-5
• Continuous venovenous hemofiltration with dialysis in combination with total hepatectomy and portocaval shunting. Bridge to liver transplantation. Hammer GB, So SK, Al-Uzri A, Conley SB, Concepcion W, Cox KL, Berquist WE, Esquivel CO. Transplantation. 1996; 62 (1): 130-2
• Cyclosporine and tacrolimus both suppress activation of Kupffer cells in vitro. Tojimbara T, Bermudez LE, Egawa H, Hayashi M, So SK, Esquivel CO. Transplant Proc. 1996; 28 (3): 1381-2
• Oral tacrolimus (FK506) induction therapy in pediatric orthotopic liver transplantation. Cacciarelli TV, Esquivel CO, Cox KL, Hayashi M, Berquist WE, Concepcion W, So SK. Transplantation. 1996; 61 (8): 1188-92
• Orthotopic liver transplantation for hepatocellular carcinoma. Factors affecting long-term patient survival. Ojogho ON, So SK, Keeffe EB, Berquist W, Concepcion W, Garcia-Kennedy R, Imperial J, Esquivel CO. Arch Surg. 1996; 131 (9): 935-9; discussion 939-41
• Primary liver transplantation without transfusion of red blood cells. Cacciarelli TV, Keeffe EB, Moore DH, Burns W, Chuljian P, Busque S, Concepcion W, So SK, Esquivel CO. Surgery. 1996; 120 (4): 698-704; discussion 704-5
• Suggested guidelines for the use of tacrolimus in pediatric liver transplant patients. Esquivel CO, So SK, McDiarmid SV, Andrews WS, Colombani PM. Transplantation. 1996; 61 (5): 847-8
• A reassessment of ABO incompatibility in pediatric liver transplantation. Cacciarelli TV, So SK, Lim J, Concepcion W, Cox K, Esquivel CO. Transplantation. 1995; 60 (7): 757-60
• Acute liver allograft rejection in the rat. An analysis of the immune response. Egawa H, Martinez OM, Quinn MB, Villanueva JC, So S, Esquivel CO, Krams SM. Transplantation. 1995; 59 (1): 97-102
• An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Cox KL, Lawrence-Miyasaki LS, Garcia-Kennedy R, Lennette ET, Martinez OM, Krams SM, Berquist WE, So SK, Esquivel CO. Transplantation. 1995; 59 (4): 524-9
• Characterization of cytokine expression in an animal model of acute liver allograft rejection. Egawa H, Martinez OM, Quinn MB, So S, Esquivel CO, Krams SM. Transplant Proc. 1995; 27 (1): 505-6
• Circulating intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in pediatric liver recipients. Lang T, Krams SM, Villanueva JC, So SK, Berquist WE, Cox KL, Esquivel CO, Martinez OM. Transplant Proc. 1995; 27 (1): 1148-9
• Differential patterns of circulating intercellular adhesion molecule-1 (cICAM-1) and vascular cell adhesion molecule-1 (cVCAM-1) during liver allograft rejection. Lang T, Krams SM, Villanueva JC, Cox K, So S, Martinez OM. Transplantation. 1995; 59 (4): 584-9
• Distinct patterns of Th2 cytokine production during immune activation in pediatric liver allograft recipients. Lang T, Krams SM, Villanueva JC, Cox K, So S, Esquivel C, Martinez OM. Transplant Proc. 1995; 27 (1): 1146-7
• Effects of pentoxifylline pretreatment on Kupffer cells in rat liver transplantation. Kozaki K, Egawa H, Bermudez L, Keefe EB, So SK, Esquivel CO. Hepatology. 1995; 21 (4): 1079-82
• Expression of cytokines and immune mediators during chronic liver allograft rejection. Hayashi M, Martinez OM, Garcia-Kennedy R, So S, Esquivel CO, Krams SM. Transplantation. 1995; 60 (12): 1533-8
• FK 506 rescue therapy for hepatic allograft rejection: experience with an aggressive approach. Woodle ES, Perdrizet GA, So SK, White HM, Marsh JW. Clin Transplant. 1995; 9 (1): 45-52
• Fulminant hepatic failure following varicella-zoster infection in a child. A case report of successful treatment with liver transplantation and perioperative acyclovir. Tojimbara T, So SK, Cox KL, Berquist WE, Egawa H, Garcia-Kennedy R, Esquivel CO. Transplantation. 1995; 60 (9): 1052-3
• Impact of reduced-size liver transplantation on rejection and liver allograft outcome in the pediatric population. Cacciarelli TV, So SK, Egawa H, Cox K, Esquivel CO. Transplant Proc. 1995; 27 (1): 1239-40
• Isolated alkaline phosphatemia following pediatric liver transplantation in the FK506 ERA. Egawa H, Berquist W, So SK, Cox K, Menegaux F, Esquivel CO. Transplantation. 1995; 59 (5): 791-3
• Liver transplantation in a child with sickle cell anemia. Lang T, Berquist WE, So SK, Cox KL, Rich EJ, Vichinsky E, Concepcion W, Esquivel CO. Transplantation. 1995; 59 (10): 1490-2
• Long-term nonresponsiveness to a liver allograft may be cytokine mediated. Egawa H, Martinez OM, Quinn MB, Villanueva JC, So S, Esquivel CO, Krams SM. Transplant Proc. 1995; 27 (1): 241-2
• Molecular markers of Epstein-Barr virus infection in the circulation of transplant recipients. Martinez OM, Villanueva JC, Lawrence-Miyasaki L, Quinn MB, Gish R, Cox K, So S, Esquivel CO, Krams SM. Transplant Proc. 1995; 27 (1): 1211-2
• The use of non-heart-beating cadaver donors in experimental liver transplantation. Tojimbara T, Kennedy RG, Burns W, Hayashi M, Krams S, Martinez O, So S, Esquivel CO. Transplantation. 1995; 60 (10): 1179-80
• Aggressive early cyclosporine therapy is desirable in pediatric renal transplantation. al-Uzri A, Conley SB, Orlandi P, So S, Salvatierra O. Transplant Proc. 1994; 26 (1): 88-90
• Ex vivo technique for right lobectomy in pediatric hepatic transplantation. Wong L, Concepcion W, So SK, Egawa H, Menegaux F, Esquivel CO. J Am Coll Surg. 1994; 179 (5): 601-3
• FK506 conversion therapy in pediatric liver transplantation. Egawa H, Esquivel CO, So SK, Cox K, Concepcion W, Lawrence L. Transplantation. 1994; 57 (8): 1169-73
• Induction immunosuppression with antilymphocyte globulin or OKT3 in cadaver kidney transplantation. Results of a single institution prospective randomized trial. Hanto DW, Jendrisak MD, So SK, McCullough CS, Rush TM, Michalski SM, Phelan D, Mohanakumar T. Transplantation. 1994; 57 (3): 377-84
• Liver transplantation at California Pacific Medical Center, San Francisco, California. Esquivel CO, Martinez O, Krams S, Lim J, So SK, Concepcion W, Cox KL, Keeffe EB. Clin Transpl. 1994: 163-71
• Neurological complications of liver transplantation in adult versus pediatric patients. Menegaux F, Keeffe EB, Andrews BT, Egawa H, Monge H, Concepcion W, So SK, Esquivel CO. Transplantation. 1994; 58 (4): 447-50
• Prevention of rejection and graft loss with an aggressive quadruple immunosuppressive therapy regimen in children and adolescents. Conley SB, al-Uzri A, So S, Salvatierra O. Transplantation. 1994; 57 (4): 540-4
• Respiratory distress from benign liver tumors: a report of two unusual cases treated with hepatic transplantation. Egawa H, Berquist W, Garcia-Kennedy R, Cox KL, Concepcion W, So SK, Esquivel CO. J Pediatr Gastroenterol Nutr. 1994; 19 (1): 114-7
• Comparative effects of blood, colloid, and Ringer's lactate terminal allograft rinse on the results of orthotopic liver transplantation. Menegaux F, Egawa H, Keeffe EB, So SK, Concepcion W, Collins GM, Esquivel CO. Transplant Proc. 1993; 25 (6): 3196-8
• Cytomegalovirus prophylaxis in pediatric renal transplant recipients. So S, Mayo C, McCullough C, Jendrisak M, Woodle S, Marsh W, Bailey T. Transplant Proc. 1993; 25 (1 Pt 2): 1414-5
• FK 506 rescue therapy: early conversion improves efficacy. Woodle ES, Perdrizet GA, So S, Jendrisak MD, White HM, Marsh JW. Transplant Proc. 1993; 25 (2): 1990-1
• FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease. Woodle ES, Perdrizet GA, So S, Jendrisak MD, White HM, Marsh JW. Transplant Proc. 1993; 25 (2): 1992-3
• Intrahepatic portosystemic vascular stents: a bridge to hepatic transplantation. Woodle ES, Darcy M, White HM, Perdrizet GA, Vesely TM, Picus D, Hicks M, So SK, Jendrisak MD, McCullough CS. Surgery. 1993; 113 (3): 344-51
• Pentoxifylline inhibits production of superoxide anion and tumor necrosis factor by Kupffer cells in rat liver preservation. Kozaki K, Egawa H, Bermudes L, Feduska NJ, So S, Esquivel CO. Transplant Proc. 1993; 25 (6): 3025-6
• Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection. Woodle ES, So S, Jendrisak MD, Perdrizet GA, White HM, Marsh JW. Transplant Proc. 1993; 25 (2): 1988-9
• Successful retransplantation after a 48-hour anhepatic state. So SK, Barteau JA, Perdrizet GA, Marsh JW. Transplant Proc. 1993; 25 (2): 1962-3
• Early occurrence of end-stage renal disease in a patient with infantile nephropathic cystinosis. Schnaper HW, Cottel J, Merrill S, Marcusson E, Kissane JM, Shackelford GD, So SK, Nelson RD, Cole BR, Smith ML. J Pediatr. 1992; 120 (4 Pt 1): 575-8
• FK506: inhibition of humoral mechanisms of hepatic allograft rejection. Woodle ES, Perdrizet GA, Brunt EM, So SK, Jendrisak MD, McCullough CS, Vehe KL, White HM, Peters MG, Mohanakumar T. Transplantation. 1992; 54 (2): 377-81
• QT prolongation and Torsades de Pointes after administration of FK506. Johnson MC, So S, Marsh JW, Murphy AM. Transplantation. 1992; 53 (4): 929-30
• A prospective randomized comparison of prophylactic ALG and OKT3 in cadaver kidney allograft recipients. Hanto DW, Jendrisak MD, McCullough CS, So SK, Marsh JW, Rush T, Michalski S, Phelan D, Mohanakumar T. Transplant Proc. 1991; 23 (1 Pt 2): 1050-1
• Anesthetic management of infants receiving an adult kidney transplant. Beebe DS, Belani KG, Mergens P, Liao JC, So SK, Najarian JS, Palahniuk RJ. Anesth Analg. 1991; 73 (6): 725-30
• FK 506: reversal of humorally mediated rejection following ABO-incompatible liver transplantation. Woodle ES, Perdrizet GA, Brunt EM, So SK, Jendrisak MD, McCullough CS, Vehe KL, White HM, Peters MG, Marsh JW. Transplant Proc. 1991; 23 (6): 2992-3
• Laparoscopic drainage of a posttransplant lymphocele. McCullough CS, Soper NJ, Clayman RV, So SS, Jendrisak MD, Hanto DW. Transplantation. 1991; 51 (3): 725-7
• Renal transplantation for systemic lupus erythematosus and recurrent lupus nephritis. A single-center experience and a review of the literature. Goss JA, Cole BR, Jendrisak MD, McCullough CS, So SK, Windus DW, Hanto DW. Transplantation. 1991; 52 (5): 805-10
• Short-term and long-term effects of HLA matching in cadaveric pancreas transplantation. So SK, Moudry-Munns KC, Gillingham K, Minford EJ, Sutherland DE. Transplant Proc. 1991; 23 (1 Pt 2): 1634-6
• Significance of B-cell crossmatch on outcome in renal transplantation. Jendrisak M, Phelan D, Marsh J, McCullough C, So S, Mohanakumar T, Rush T, Michalski S, Hanto D. Transplant Proc. 1991; 23 (1 Pt 1): 434-6
• Successful kidney transplantation in infants. Najarian JS, Frey DJ, Matas AJ, So SK, Cook M, Mauer SM, Chavers BM, Kashtan C, Gillingham KJ, Nevins TE. Transplant Proc. 1991; 23 (1 Pt 2): 1382-3
• Reversible hepatic transplant ischemia: case report and review of literature. Castaneda F, So SK, Hunter DW, Castaneda-Zuniga WR, Amplatz K. Cardiovasc Intervent Radiol. 1990 Apr-May; 13 (2): 88-90
• DR matching improves cadaveric pancreas transplant results. So SK, Minford EJ, Moudry-Munns KC, Gillingham K, Sutherland DE. Transplant Proc. 1990; 22 (2): 687-8
• Renal transplantation in infants. Najarian JS, Frey DJ, Matas AJ, Gillingham KJ, So SS, Cook M, Chavers B, Mauer SM, Nevins TE. Ann Surg. 1990; 212 (3): 353-65; discussion 366-7
• The use of cadaver kidneys for transplantation in young children. So SK, Gillingham K, Cook M, Mauer SM, Matas A, Nevins TE, Chavers BM, Najarian JS. Transplantation. 1990; 50 (6): 979-83
• Afferent and efferent pathways in T cell responses to MHC class I+, II-hepatocytes. Bumgardner GL, Chen S, Hoffman R, Cahill DC, So SK, Platt J, Bach FH, Ascher NL. Transplantation. 1989; 47 (1): 163-70
• In vitro immunosuppressive effects of murine hepatocyte cytosol. Bumgardner GL, Billiar T, So SK, Chen S, Dunn G, Payne W, Ascher NL. Transplant Proc. 1989; 21 (1 Pt 1): 1154-5
• A comparison of three immunosuppressive protocols in patients aged over 50 years. Fryd DS, So SK, Kruse L, Canafax DM, Sutherland DE, Simmons RL, Najarian JS. Transplant Proc. 1987; 19 (1 Pt 2): 1530-1
• Class I major histocompatibility complex antigens are induced on hepatocytes in rejecting human liver grafts. So SK, Snover DC, Ascher NL, Platt JL. Transplant Proc. 1987; 19 (1 Pt 3): 2464-5
• Dialysis access: radiographic evaluation and management. Hunter DW, So SK. Radiol Clin North Am. 1987; 25 (2): 249-60
• First kidney transplants in children 5 years of age or younger. Najarian JS, So SK, Simmons RL, Mauer SM, Nevins TE, Sutherland DE, Ascher NL, Chavers BM, Payne WD, Fryd DS. Transplant Proc. 1987; 19 (1 Pt 3): 2111-2
• Growth and development in infants after renal transplantation. So SK, Chang PN, Najarian JS, Mauer SM, Simmons RL, Nevins TE. J Pediatr. 1987; 110 (3): 343-50
• Increased expression of class I major histocompatibility complex antigens on hepatocytes in rejecting human liver allografts. So SK, Platt JL, Ascher NL, Snover DC. Transplantation. 1987; 43 (1): 79-85
• Low-dose cyclosporine therapy combined with standard immunosuppression in pediatric renal transplantation. So SK, Najarian JS, Nevins TE, Fryd DS, Knaak M, Chavers B, Mauer SM, Simmons RL. J Pediatr. 1987; 111 (6 Pt 2): 1017-21
• Major histocompatibility complex class I antigens on hepatocytes in human liver grafts. Platt JL, Ascher NL, Snover DC, So SK. Transplant Proc. 1987; 19 (4 Suppl 3): 66-7
• Purified hepatocytes can stimulate allospecific cytolytic T lymphocytes in a mixed lymphocyte-hepatocyte culture. So SK, Wilkes LM, Platt JL, Ascher NL, Simmons RL. Transplant Proc. 1987; 19 (1 Pt 1): 251-2
• Renal transplantation at the University of Minnesota during the 1980s. Fryd DS, Migliori R, Simmons RL, Chavers B, Dunn D, Payne W, Canafax DM, Sutherland DE, So SS, Mauer SM. Clin Transpl. 1987: 167-81
• Preliminary results of low-dose cyclosporin A in pediatric renal transplantation. Nevins TE, Knaak M, So SK, Chavers B, Melvin T, Simmons RL, Mauer SM, Najarian JS. Int J Pediatr Nephrol. 1986 Apr-Jun; 7 (2): 91-4
• Current results in pediatric renal transplantation at the University of Minnesota. So SK, Mauer SM, Nevins TE, Fryd DS, Sutherland DE, Ascher NL, Simmons RL, Najarian JS. Kidney Int Suppl. 1986: 19 S25-30
• The outcome of 304 primary renal transplants in children (1968-1985). Najarian JS, So SK, Simmons RL, Fryd DS, Nevins TE, Ascher NL, Sutherland DE, Payne WD, Chavers BM, Mauer SM. Ann Surg. 1986; 204 (3): 246-58
• Improved results of multiple renal transplantation in children. So SK, Simmons RL, Fryd DS, Najarian JS, Mauer SM. Surgery. 1985; 98 (4): 729-38
• Thrombosed synthetic hemodialysis access fistulas: failure of fibrinolytic therapy. Young AT, Hunter DW, Castaneda-Zuniga WR, So SK, Mercado S, Cardella JF, Amplatz K. Radiology. 1985; 154 (3): 639-42
• Hickman catheter for pediatric hemodialysis: a 3-year experience. So SK, Mahan JD, Mauer SM, Sutherland DE, Nevins TE. Trans Am Soc Artif Intern Organs. 1984: 30 619-23
• Long-term effect of splenectomy versus no splenectomy in renal transplant patients. Reanalysis of a randomized prospective study. Sutherland DE, Fryd DS, So SK, Bentley FR, Ascher NL, Simmons RL, Najarian JS. Transplantation. 1984; 38 (6): 619-24
• Bile ascites during infancy: diagnosis using Disofenin Tc 99m sequential scintiphotography. So SK, Lindahl JA, Sharp HL, Cook AM, Leonard AS. Pediatrics. 1983; 71 (3): 402-5
• Failing or thrombosed Brescia-Cimino arteriovenous dialysis fistulas. Angiographic evaluation and percutaneous transluminal angioplasty. Hunter DW, So SK, Castaneda-Zuniga WR, Coleman CE, Sutherland DE, Amplatz K. Radiology. 1983; 149 (1): 105-9
• HBV markers in Chinese in Hong Kong. Lam KC, Yuen P, Colbourne MJ, Chang J, So S. Ann Acad Med Singapore. 1980; 9 (2): 149-51
• The combined effect of radiotherapy and neuraminidase-treated tumor cells on 3-methylcholanthrene-induced fibrosarcoma. So SK, Song CW, Rios A, Simmons RL. J Surg Oncol. 1977; 9 (6): 527-40